Commit To Purchase Supernus Pharmaceuticals At $26, Earn 15.3% Annualized Using Options
April 07, 2017 at 11:49 AM EDT
Investors considering a purchase of Supernus Pharmaceuticals Inc (SUPN) stock, but cautious about paying the going market price of $30.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $26 strike, which has a bid at the time of this writing of $1.75..